Roger S. Mazze

3.4k total citations
68 papers, 2.2k citations indexed

About

Roger S. Mazze is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Roger S. Mazze has authored 68 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 13 papers in Obstetrics and Gynecology. Recurrent topics in Roger S. Mazze's work include Diabetes Management and Research (41 papers), Diabetes Management and Education (17 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (14 papers). Roger S. Mazze is often cited by papers focused on Diabetes Management and Research (41 papers), Diabetes Management and Education (17 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (14 papers). Roger S. Mazze collaborates with scholars based in United States, United Kingdom and Belgium. Roger S. Mazze's co-authors include Oded Langer, David Lucido, Harry Shamoon, Richard M. Bergenstal, Lois Brustman, Akolisa Anyaegbunam, Oded Langer, Ellie S. Strock, RoseMarie Pasmantier and ARLENE MONK and has published in prestigious journals such as PLoS ONE, Diabetes Care and Diabetes.

In The Last Decade

Roger S. Mazze

68 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger S. Mazze United States 23 1.5k 644 505 351 228 68 2.2k
Klaus Jeitler Austria 20 1.2k 0.8× 718 1.1× 247 0.5× 408 1.2× 131 0.6× 47 2.2k
Charles M. Clark United States 22 1.2k 0.8× 360 0.6× 108 0.2× 235 0.7× 286 1.3× 68 2.1k
Gary T.C. Ko China 22 861 0.6× 186 0.3× 115 0.2× 112 0.3× 110 0.5× 41 1.7k
H. Hanaire France 29 1.9k 1.3× 1.2k 1.9× 72 0.1× 812 2.3× 203 0.9× 94 2.6k
T. Lauritzen Denmark 32 2.3k 1.5× 500 0.8× 45 0.1× 457 1.3× 263 1.2× 81 3.4k
C. Druet France 17 474 0.3× 157 0.2× 127 0.3× 132 0.4× 112 0.5× 27 1.4k
Pirjo Härkönen Finland 20 1.1k 0.7× 175 0.3× 48 0.1× 292 0.8× 201 0.9× 35 2.2k
Anastasia Thanopoulou Greece 17 476 0.3× 143 0.2× 127 0.3× 114 0.3× 61 0.3× 38 1.3k
Athena Philis‐Tsimikas United States 31 3.1k 2.1× 1.0k 1.6× 48 0.1× 623 1.8× 555 2.4× 116 3.9k
American Diabetes Association Australia 7 692 0.5× 192 0.3× 35 0.1× 181 0.5× 110 0.5× 8 1.1k

Countries citing papers authored by Roger S. Mazze

Since Specialization
Citations

This map shows the geographic impact of Roger S. Mazze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger S. Mazze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger S. Mazze more than expected).

Fields of papers citing papers by Roger S. Mazze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger S. Mazze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger S. Mazze. The network helps show where Roger S. Mazze may publish in the future.

Co-authorship network of co-authors of Roger S. Mazze

This figure shows the co-authorship network connecting the top 25 collaborators of Roger S. Mazze. A scholar is included among the top collaborators of Roger S. Mazze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger S. Mazze. Roger S. Mazze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Distiller, Larry A., Iain Cranston, & Roger S. Mazze. (2016). First Clinical Experience with Retrospective Flash Glucose Monitoring (FGM) Analysis in South Africa. Journal of Diabetes Science and Technology. 10(6). 1294–1302. 38 indexed citations
2.
Perkins, Bruce A., David Z.I. Cherney, Nima Soleymanlou, et al.. (2015). Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes. PLoS ONE. 10(11). e0141085–e0141085. 29 indexed citations
3.
Mazze, Roger S., et al.. (2013). Diurnal Glucose Profiles Using Continuous Glucose Monitoring to Identify the Glucose-Lowering Characteristics of Colesevelam HCL (WELCHOL). Endocrine Practice. 19(2). 275–283. 5 indexed citations
4.
Bolli, Geremia B., Larry C. Deeb, Satish K. Garg, et al.. (2011). International Forum for the Advancement of Diabetes Research and Care, April 29–30, 2011, Athens, Greece. Diabetes Technology & Therapeutics. 13(9). 967–979. 2 indexed citations
5.
Mazze, Roger S., et al.. (2011). An overview of continuous glucose monitoring and the ambulatory glucose profile.. PubMed. 94(8). 40–4. 10 indexed citations
6.
7.
Mazze, Roger S., Margaret A. Powers, Harry P. Wetzler, & Cori L. Ofstead. (2008). Partners in Advancing Care and Education Solutions Study: Impact on Processes and Outcomes of Diabetes Care. Population Health Management. 11(6). 297–305. 5 indexed citations
8.
Mazze, Roger S., Ellie S. Strock, Gregg D. Simonson, & Richard M. Bergenstal. (2006). Staged Diabetes Management. 10 indexed citations
9.
Mazze, Roger S., et al.. (2004). Undetected, uncontrolled blood pressure in type 2 diabetes: self‐monitored blood pressure profiles. Blood Pressure. 13(6). 335–342. 10 indexed citations
10.
Mazze, Roger S., et al.. (2004). Diabetes in the Hispanic population. Postgraduate Medicine. 116(6). 26–36. 10 indexed citations
11.
Mazze, Roger S., Ellie S. Strock, Gregg D. Simonson, & Richard M. Bergenstal. (2004). Staged Diabetes Management: A Systematic Approach. 20 indexed citations
12.
Simonson, Gregg D., et al.. (2000). Prevention of diabetes related amputations in an American Indian community using staged diabetes management. Diabetes Research and Clinical Practice. 50. 408–408. 2 indexed citations
13.
Franz, Marion J., ARLENE MONK, Barbara Barry, et al.. (1995). Effectiveness of Medical Nutrition Therapy Provided by Dietitians in the Management of Non–Insulin-Dependent Diabetes Mellitus. Journal of the American Dietetic Association. 95(9). 1009–1017. 217 indexed citations
14.
Franz, Marion J., Patricia L. Splett, ARLENE MONK, et al.. (1995). Cost-Effectiveness of Medical Nutrition Therapy Provided by Dietitians for Persons with Non–Insulin-Dependent Diabetes Mellitus. Journal of the American Dietetic Association. 95(9). 1018–1024. 85 indexed citations
15.
Mazze, Roger S.. (1994). A systems approach to diabetes care.. PubMed. 17 Suppl 1. 5–11. 8 indexed citations
16.
Etzwiler, Donnell D., et al.. (1993). A Joint Venture With the Commonwealth of Independent States. Diabetes Care. 16(1). 394–397. 1 indexed citations
17.
Peterson, Kevin, et al.. (1993). Glucose intolerance as a consequence of oral terbutaline treatment for preterm labor.. PubMed. 36(1). 25–31. 3 indexed citations
18.
Langer, Oded & Roger S. Mazze. (1988). The relationship between large-for-gestational-age infants and glycemic control in women with gestational diabetes. American Journal of Obstetrics and Gynecology. 159(6). 1478–1483. 128 indexed citations
19.
Shamoon, Harry, et al.. (1986). Assessment of long-term glycemia in type I diabetes using multiple blood glucose values stored in a memory-containing reflectometer. The American Journal of Medicine. 80(6). 1086–1092. 11 indexed citations
20.
Wylie‐Rosett, Judith, et al.. (1985). Professional Education in a Long-Term-Care Facility: Program Development in Diabetes. Diabetes Care. 8(5). 481–485. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klaus Jeitler Breakdown of academic impact, for papers by Charles M. Clark Breakdown of academic impact, for papers by Gary T.C. Ko Breakdown of academic impact, for papers by H. Hanaire Breakdown of academic impact, for papers by T. Lauritzen Breakdown of academic impact, for papers by C. Druet Breakdown of academic impact, for papers by Pirjo Härkönen Breakdown of academic impact, for papers by Anastasia Thanopoulou Breakdown of academic impact, for papers by Athena Philis‐Tsimikas Breakdown of academic impact, for papers by American Diabetes Association
Rankless by CCL
2026